Cargando…
Safety of autologous freshly expanded mesenchymal stromal cells for the treatment of graft-versus-host disease
Despite the curative potential of hematopoietic cell transplantation (HCT) for hematologic malignancies, graft-versus-host disease (GVHD) remains a substantial cause of morbidity and mortality, particularly if treatment is refractory. Treatment with additional immunosuppression including steroids of...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515357/ https://www.ncbi.nlm.nih.gov/pubmed/36189324 http://dx.doi.org/10.3389/fimmu.2022.959658 |